Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.03 USD | +4.12% | -1.94% | +13.48% |
05-22 | Earnings Flash (NRXS) NEURAXIS Posts Q1 Revenue $646,635 | MT |
05-22 | Neuraxis, Inc. Provides Earnings Guidance for Late 2024 and 2025 | CI |
Business Summary
Number of employees: 19
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical Neuromodulation Devices
100.0
%
| 3 | 100.0 % | 2 | 100.0 % | -8.37% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 3 | 100.0 % | 2 | 100.0 % | -8.37% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gary Peterson
FOU | Founder | - | 10-12-31 |
Brian Carrico
CEO | Chief Executive Officer | 42 | 11-12-31 |
Timothy Henrichs
DFI | Director of Finance/CFO | 51 | 02-04 |
Adrian Miranda
CTO | Chief Tech/Sci/R&D Officer | 54 | 17-12-31 |
Tom Carrico
CMP | Compliance Officer | 67 | 12-01-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Brian Carrico
CEO | Chief Executive Officer | 42 | 11-12-31 |
Founder | 70 | 10-12-31 | |
Tom Carrico
CMP | Compliance Officer | 67 | 12-01-31 |
Beth Keyser
BRD | Director/Board Member | 55 | - |
Adrian Miranda
CTO | Chief Tech/Sci/R&D Officer | 54 | 17-12-31 |
Bradley Watkins
BRD | Director/Board Member | 49 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 6,647,960 | 3,368,652 ( 50.67 %) | 0 | 50.67 % |
Company contact information
Sector
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+13.48% | 19.98M | |
+75.33% | 12.54B | |
-24.19% | 7.39B | |
+6.43% | 6.62B | |
+13.59% | 5.43B | |
+34.82% | 4.81B | |
-14.56% | 4.8B | |
-25.57% | 3.72B | |
-26.93% | 2.76B | |
+49.43% | 2.4B |
- Stock Market
- Equities
- NRXS Stock
- Company NeurAxis, Inc.